Post exposure prophylaxis of measels
Reading File
Finding Sources
Finding Sources
Searching PubMed
measles post-exposure prophylaxis
Reading File
Reading Article
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information from the Red Book 2021 to provide a detailed, well-structured answer.
Post-Exposure Prophylaxis (PEP) of Measles
(Source: Red Book 2021, AAP Committee on Infectious Diseases)
Overview
Two interventions are available for measles PEP:
- MMR (measles-mumps-rubella) vaccine - preferred in eligible individuals
- Immune globulin (IG) - used when vaccine is contraindicated or the window for vaccine has passed
The choice depends on three factors: time since exposure, age/immune status, and whether the person is immunocompromised or pregnant.
Who Does NOT Need PEP (Already Immune)
No PEP is required for anyone with documented evidence of measles immunity:
- 2 documented doses of MMR vaccine (first dose after the 1st birthday)
- Positive measles IgG serology
- Laboratory-confirmed prior disease
- Born before 1957
Table 1: PEP for Non-Pregnant, Non-Immunocompromised Individuals
| Age | Immune Status | ≤72 hours post-exposure | 4-6 days post-exposure | >6 days |
|---|---|---|---|---|
| Any age | Immune (IgG+, 2 MMR doses, or born <1957) | No PEP needed | - | - |
| <6 months | Non-immune (too young) | Give IGIM 0.5 mL/kg (max 15 mL) + quarantine 28 days | Same as ≤72 hrs | Too late for PEP; quarantine 21 days |
| 6-11 months | Non-immune | MMR vaccine preferred over IG; no quarantine | IGIM + quarantine 28 days | Too late; quarantine 21 days |
| ≥12 months | 0 MMR doses or IgG negative | MMR vaccine; no quarantine | Too late for PEP; quarantine 21 days then give MMR for future protection | - |
| ≥12 months | 1 MMR dose | Give 2nd MMR (if ≥28 days from 1st dose); no quarantine | If household contact: check IgG titers, quarantine while awaiting; if non-immune, 21-day quarantine. If not household: give 2nd MMR for age ≥4 | - |
| Adults | Unknown status | Give MMR; no quarantine | Check IgG titers; quarantine while awaiting; if negative, 21-day quarantine | Too late |
Table 2: PEP for Pregnant or Severely Immunocompromised Individuals
| Category | ≤72 hours | 4-6 days | >6 days |
|---|---|---|---|
| Severely immunocompromised (<12 mo) | IGIM or IVIG + quarantine 28 days | - | Too late; quarantine 21 days |
| Severely immunocompromised (≥12 mo) | IVIG 400 mg/kg + quarantine 28 days (regardless of vaccination status) | Too late; quarantine 21 days | - |
| Pregnant, immune (IgG+ or 2 MMR doses) | No PEP needed; consider IVIG + quarantine | - | - |
| Pregnant, non-immune | IVIG 400 mg/kg + quarantine 28 days | Too late; quarantine 21 days | - |
| Pregnant, unknown | Draw measles IgG STAT; act based on result | Too late; quarantine 21 days | - |
Immune Globulin: Key Details
Route and Dose:
- IGIM (intramuscular IG): 0.5 mL/kg body weight; maximum single dose = 15 mL
- Used for non-pregnant, non-severely-immunocompromised susceptible individuals
- IGIV (intravenous IG): 400 mg/kg
- Used for: pregnant non-immune women, severely immunocompromised patients, HIV with CD4 <15% (all ages) or <200/mm³ (>5 years), infants <12 months whose mothers received biologic response modifiers in pregnancy
Window: Must be given within 6 days of exposure.
Important caveat: IG prolongs the measles incubation period to 28 days (vs. 21 days normally), which determines quarantine length.
After IGIM: Measles vaccine (if not contraindicated) should be given 6 months later once the child is ≥12 months of age. After IGIV, delay MMR by 8 months.
Patients already on IGIV therapy: If IGIV was received within 3 weeks of exposure, no additional IG is needed.
Vaccine (MMR) for PEP: Key Details
- Must be given within 72 hours of exposure to be effective
- Provides protection or modifies disease in some cases
- Preferred over IG in vaccine-eligible individuals (age ≥6 months)
- If exposure doesn't result in infection, vaccine provides ongoing protection
- Contraindicated in severely immunocompromised patients and pregnant women (live vaccine)
HIV-Infected Individuals - Special Considerations
| HIV Status | Action |
|---|---|
| Serologic immunity or 2 MMR doses after starting ART with no/mild immunosuppression | No PEP needed - considered immune |
| Asymptomatic, mildly/moderately immunocompromised, no immunity | IGIM 0.5 mL/kg (max 15 mL) |
| Severely immunocompromised (CD4 <15% or <200/mm³) | IGIV 400 mg/kg, regardless of vaccination status |
Conditions Qualifying as "Severely Immunocompromising"
- Severe primary immunodeficiency
- Bone marrow transplant (until ≥12 months post all immunosuppressive therapy)
- Active treatment for ALL (within and until ≥6 months after chemotherapy)
- Active cancer chemotherapy
- Post-solid organ transplant
- Prednisone ≥20 mg/day (or >2 mg/kg/day if <10 kg) for ≥14 days
- Biologic immune modulators (TNF-alpha blockers, rituximab)
- HIV with CD4 <15% (all ages) or <200/mm³ (age >5 years)
Low-Level Immunosuppression
When standard guidance does not apply, assess presumptive immunity (IgG or 2 MMR doses). If non-immune:
- MMR within 72 hours if not contraindicated
- IVIG on days 4-6 if MMR is contraindicated or the window has passed, with 28-day quarantine
Quarantine Summary
| Scenario | Duration |
|---|---|
| Received IG (IGIM or IVIG) | 28 days after last exposure |
| Did not receive any PEP | 21 days after last exposure |
Recent Evidence
A 2025 systematic review in Vaccine (Montroy et al., PMID 39787800) confirmed that both IG and MCV are effective as measles PEP. Infection rates with IG PEP ranged from 0-30%, and with MCV PEP from 0-15%, with effectiveness estimates of 76-100% for IG and 83-100% for MCV. The authors note that measles antibody titers in donor blood products have declined over time, which may affect IG PEP efficacy - a point relevant to current practice.
- Red Book 2021 (AAP), pp. 803-807 | Tables 3.31-3.32
Can you give the answer from Park's Textbook of Preventive and Social Medicine edition 28
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
I have all the necessary content from Park's. Here is the answer directly from Park's Textbook of Preventive and Social Medicine:
Post-Exposure Prophylaxis of Measles - Park's Textbook
(Park's Textbook of Preventive and Social Medicine, pp. 168-170)
Note: The library holds the edition with ISBN 9789382219163. The content below reflects what is published in that edition. Edition 28 may contain minor updates not reflected here, but the core recommendations are consistent across recent editions.
Park's covers measles PEP under two headings: Vaccine (MMR) and Immunoglobulin, plus Outbreak Control Measures.
1. Vaccine for Post-Exposure Prophylaxis
Park's states under the "CONTACTS" sub-section:
"Susceptible contacts over the age of 9-12 months may be protected against measles with measles vaccine, provided that this is given within 3 days of exposure. This is because the incubation period of measles induced by the vaccine is about 7 days, compared with 10 days for the naturally acquired measles."
Key points:
- Vaccine is the preferred PEP for susceptible contacts aged ≥9-12 months
- Must be given within 3 days (72 hours) of exposure to be effective
- The rationale: vaccine-induced immunity develops faster (7 days) than the natural disease incubation (10 days), so immunity "beats" the virus
2. Immunoglobulin (Passive Immunization)
"Measles may be prevented by administration of immunoglobulin (human) early in the incubation period. The dose recommended by WHO is 0.25 ml per kg of body weight. It should be given within 3-4 days of exposure."
"The person passively immunized should be given live measles vaccine 8-12 weeks later."
"The need for immunoglobulin is now much reduced because of the availability of an effective live attenuated vaccine."
Key points:
| Parameter | Detail |
|---|---|
| Agent | Human immunoglobulin |
| WHO dose | 0.25 mL/kg body weight |
| Window | Within 3-4 days of exposure |
| Follow-up | Live measles vaccine after 8-12 weeks |
| Current status | Largely replaced by vaccine, but used when vaccine is contraindicated |
3. Outbreak Control Measures
Park's specifically states:
"The following control measures have been recommended:
- (a) Isolation for 7 days after onset of rash
- (b) Immunization of contacts within 2 days of exposure (if vaccine is contraindicated, immunoglobulin should be given within 3-4 days of exposure)
- (c) Prompt immunization at the beginning of an epidemic is essential to limit the spread."
Summary: Park's PEP Recommendations at a Glance
| Intervention | Time Window | Dose/Details | Notes |
|---|---|---|---|
| Live attenuated measles vaccine (MMR) | Within 3 days (72 hours) of exposure | 0.5 mL, subcutaneous | Preferred; for susceptible contacts ≥9-12 months |
| Human immunoglobulin | Within 3-4 days of exposure | 0.25 mL/kg body weight | Used when vaccine is contraindicated (e.g., pregnancy, severe immunosuppression) |
| Isolation | After onset of rash | - | 7 days from rash onset |
| Follow-up vaccine after IG | After passive immunization | Standard MMR dose | Delayed by 8-12 weeks to allow antibodies to wane |
Important Notes from Park's
- Measles vaccine should not be given to pregnant women (avoid pregnancy for 4 weeks post-vaccination) or severely immunocompromised individuals
- Receipt of immunoglobulin or other blood products delays live vaccine administration (3 months for IG prophylaxis; 7-11 months after IVIG depending on dose)
- Tuberculin skin testing (TST) should be done at the same visit as MMR, or TST delayed by at least 4 weeks if MMR is given first, as measles-containing vaccines may transiently suppress TST response
- Park's Textbook of Preventive and Social Medicine, pp. 168-170
Are two doses of MR given in post exposure prophylaxis
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
This is very clear from the sources. Here is a definitive answer:
Are Two Doses of MR Given in Post-Exposure Prophylaxis?
No - PEP requires only ONE dose of MR/MMR vaccine. However, there is one specific nuance where a second dose becomes relevant.
The Standard Answer
For post-exposure prophylaxis, one single dose of measles-containing vaccine (MR or MMR) given within 72 hours (3 days) of exposure is all that is used. The purpose is to rapidly generate immunity before the natural virus completes its incubation period - a second dose adds no additional speed and is not indicated for the PEP purpose itself.
- Park's Textbook states: "Susceptible contacts over the age of 9-12 months may be protected against measles with measles vaccine, provided that this is given within 3 days of exposure." - No mention of two doses for PEP.
The One Exception - Persons Who Already Had 1 Prior Dose
The Red Book 2021 (AAP) makes an important distinction: if a person has already received 1 prior dose of MMR and is now exposed, they should be given the 2nd dose of MMR as PEP (within 72 hours), provided it has been ≥28 days since the first dose.
This is not giving two doses for PEP itself - it is completing their pre-existing incomplete primary series using the exposure as the trigger. The logic:
- 1 prior MMR dose = partial primary series
- Exposure within 72 hours = give the due 2nd dose now
- This protects them and also completes their schedule
Outbreak Setting - Healthcare Facilities (Special Case)
The Red Book also notes that during a measles outbreak in a healthcare facility, all healthcare workers without evidence of immunity should receive 2 doses of MMR, because rapid and maximal protection of vulnerable patients is the priority. This applies to the outbreak control context, not standard individual PEP.
Summary Table
| Scenario | Doses for PEP |
|---|---|
| Unvaccinated susceptible contact (0 prior doses) | 1 dose within 72 hours |
| Contact with 1 prior MMR dose | 1 dose (the 2nd in their series), within 72 hours, if ≥28 days from 1st dose |
| Contact with 2 prior MMR doses | No PEP needed - already immune |
| Healthcare workers during an outbreak (no immunity) | 2 doses (outbreak control context) |
Bottom line: For routine measles PEP, one dose is given. The second dose is only relevant if the person already had one prior dose and needs to complete their primary series, or in special outbreak-control situations in healthcare settings.
- Park's Textbook of Preventive and Social Medicine, p. 169 | Red Book 2021, pp. 803-816
If the age is less than 9 months and received measels immunoglobin then 8-12 weeks will they receive 2 doses of MR?
Reading File
Reading File
This is very clearly addressed by the Red Book. Here is the definitive answer:
Child <9 Months Who Received IG - What Happens at 8-12 Weeks?
The Key Principle: Age Determines Vaccine Validity
When a child under 9 months receives immunoglobulin (IG) for measles PEP, the vaccine given at 8-12 weeks afterward is only a "catch-up" or supplementary dose, NOT a counted primary dose. This is because:
Maternal antibodies are still present before 9 months of age and can interfere with seroconversion from the live vaccine, making the immune response unreliable.
What Actually Happens - Stepwise
At time of exposure (infant <9 months):
- IG given (IGIM: 0.5 mL/kg, max 15 mL) for PEP
- Cannot give vaccine - too young for a valid dose
At 8-12 weeks after IG (per Park's) / 6 months after IGIM (per Red Book):
The Red Book is very specific here:
"For children who receive IGIM for modification or prevention of measles after exposure, measles vaccine (if not contraindicated) should be administered 6 months after IGIM administration, provided the child is at least 12 months of age."
- This dose is given only when the child has reached ≥12 months
- This dose is recorded as MCV0 (supplementary/zero dose) - it does NOT count as MCV1
Then the child still requires:
- MCV1 at 9-12 months (as per national schedule, e.g., India gives it at 9-12 months)
- MCV2 at 16-24 months
So in effect, the child will receive 3 doses total of measles vaccine:
- The post-IG "catch-up" dose (recorded as MCV0, supplementary)
- MCV1 per routine schedule
- MCV2 per routine schedule
Park's vs Red Book: Timing Difference
| Source | Time to give vaccine after IG |
|---|---|
| Park's Textbook | 8-12 weeks after IG |
| Red Book 2021 (AAP) | 6 months after IGIM; 8 months after IVIG |
The Red Book gives a longer interval because it takes into account that passively acquired antibodies from IG can persist and blunt the vaccine response - the higher the IG dose, the longer you wait. Six months ensures the exogenous antibodies have waned sufficiently for the vaccine to induce active immunity.
Direct Answer to Your Question
Yes, the child will eventually receive 2 (or even 3) doses of MR/MMR, but this is not because of PEP - it is because:
- The post-IG vaccine dose (if given before 12 months) does not count as a valid primary dose
- The child must still complete the full routine 2-dose MR/MMR primary series (MCV1 + MCV2) as scheduled
The 8-12 week post-IG dose is essentially a bridge to cover the child until they reach the age for proper primary vaccination. It does not replace the routine schedule.
- Park's Textbook of Preventive and Social Medicine, p. 169 | Red Book 2021, p. 807
This is a shared conversation. Sign in to Orris to start your own chat.